Trials / Terminated
TerminatedNCT04266613
TruGraf® Testing in High-Risk Kidney Transplant Recipients
Molecular Biomarkers in Renal Transplant Recipients at Higher Risk of Acute Rejection
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 19 (actual)
- Sponsor
- Transplant Genomics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational study to evaluate TruGraf® testing in high immune risk kidney transplant recipients. TruGraf is the first and only non-invasive test approved by Medicare to rule out silent rejection in stable kidney transplant recipients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | TruGraf® Testing | 5 mL collection PAXgene blood sample |
Timeline
- Start date
- 2020-02-20
- Primary completion
- 2021-06-23
- Completion
- 2021-06-23
- First posted
- 2020-02-12
- Last updated
- 2021-09-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04266613. Inclusion in this directory is not an endorsement.